International Network of VENous Thromboembolism Clinical Research Networks


Site News
« Back to listings

INVENT Endorsed RIVASVT-100 Pilot Study (Treatment of Splanchnic Vein Thrombosis With Rivaroxaban: A Pilot, Prospective Cohort Study) has 64 patients of 100 patients - as of January 2019. The study is expected to complete recruitment this spring/summer with 36 patients remaining to recruit and new Canadian sites participating in the international study.

For more information about the pilot study, please visit the clinical trials page.


There are currently no comments.

Log in to post a comment.


* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.